[go: up one dir, main page]

WO2010147440A3 - Health food or pharmaceutical composition comprising chestnut shell extract - Google Patents

Health food or pharmaceutical composition comprising chestnut shell extract Download PDF

Info

Publication number
WO2010147440A3
WO2010147440A3 PCT/KR2010/003983 KR2010003983W WO2010147440A3 WO 2010147440 A3 WO2010147440 A3 WO 2010147440A3 KR 2010003983 W KR2010003983 W KR 2010003983W WO 2010147440 A3 WO2010147440 A3 WO 2010147440A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
health food
chestnut shell
shell extract
pruritus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/003983
Other languages
French (fr)
Korean (ko)
Other versions
WO2010147440A2 (en
Inventor
심범
김선영
김혁
고재영
윤정훈
서정아
윤준원
임경민
주영협
박영호
이창석
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Priority to KR1020117031657A priority Critical patent/KR101338681B1/en
Priority to CN2010800359033A priority patent/CN102458156A/en
Priority to JP2012515997A priority patent/JP2012530699A/en
Publication of WO2010147440A2 publication Critical patent/WO2010147440A2/en
Publication of WO2010147440A3 publication Critical patent/WO2010147440A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a health food or pharmaceutical composition for alleviating or suppressing pruritus, comprising chestnut shell extract as an active ingredient. In one example of the present invention, the chestnut shell extract comprised in the health food or pharmaceutical composition of the present invention can suitably be used as the active ingredient of a health food or pharmaceutical composition for alleviating or suppressing pruritus as it has been confirmed that it can exhibit an outstanding effect in alleviating or suppressing pruritus by suppressing the activity of proteinase-activated receptor-2 (PAR-2) which is a source of stimulation in pruritus.
PCT/KR2010/003983 2009-06-18 2010-06-18 Health food or pharmaceutical composition comprising chestnut shell extract Ceased WO2010147440A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020117031657A KR101338681B1 (en) 2009-06-18 2010-06-18 Health food or pharmaceutical composition comprising chestnut shell extract
CN2010800359033A CN102458156A (en) 2009-06-18 2010-06-18 Health food or pharmaceutical composition containing chestnut peel extract
JP2012515997A JP2012530699A (en) 2009-06-18 2010-06-18 Health food or pharmaceutical composition containing chestnut skin extract

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20090054579 2009-06-18
KR10-2009-0054579 2009-06-18

Publications (2)

Publication Number Publication Date
WO2010147440A2 WO2010147440A2 (en) 2010-12-23
WO2010147440A3 true WO2010147440A3 (en) 2011-03-31

Family

ID=43356951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/003983 Ceased WO2010147440A2 (en) 2009-06-18 2010-06-18 Health food or pharmaceutical composition comprising chestnut shell extract

Country Status (4)

Country Link
JP (1) JP2012530699A (en)
KR (1) KR101338681B1 (en)
CN (2) CN102458156A (en)
WO (1) WO2010147440A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3246B1 (en) 2009-09-09 2018-03-08 Regeneron Pharma High affinity human antibodies to human protease-activated receptor-2
KR101595959B1 (en) * 2013-02-18 2016-02-19 재단법인 대구테크노파크 Composition for preventing, improving or treating allergic dermatitis comprising hot water extract or ferment extract of chestnut inner shell
KR101643048B1 (en) * 2014-10-23 2016-07-27 단국대학교 천안캠퍼스 산학협력단 Composition for antiinflammatory and inflammatory neurodegenerative diseases comprising castanea crenata inner shell extract
CN104770644A (en) * 2015-04-29 2015-07-15 唐凯 Diabetes health care product based on affinal drugs and diet
WO2018021476A1 (en) * 2016-07-29 2018-02-01 株式会社 サティス製薬 Chestnut-skin extract
CN107686451B (en) * 2017-09-29 2020-07-03 烟台新时代健康产业日化有限公司 Preparation method of chestnut skin extract containing ceramide
KR102165675B1 (en) 2018-10-17 2020-10-14 강진영 A cosmetic manufacturing method comprising an extract extracted from chestnuts or a peptide fraction isolated therefrom and natural caffeine derived from coffee
WO2021084760A1 (en) * 2019-11-01 2021-05-06 株式会社 資生堂 Method for skin state evaluation using activated par-2 in skin as index, method for screening par-2 activation promoter or inhibitor, and par-2 activation inhibitor
FR3124947A1 (en) * 2021-07-12 2023-01-13 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Ingestible composition (Ci) for use in the treatment of a skin disorder induced by an intestinal disorder
KR20240149303A (en) 2023-04-04 2024-10-14 연세대학교 산학협력단 a novel compound derived from chestnut pericarp and composition for improving hair loss containing the compound

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100253843B1 (en) * 1997-02-14 2000-07-01 유상옥 Whitening agent containing Yulpi extract
KR20000065305A (en) * 1999-04-01 2000-11-15 유상옥 Skin care composition containing stabilized retinol, phytosphingosine, and Castaneae crenata extracts
KR20010092070A (en) * 2000-03-20 2001-10-24 유상옥,송운한 Skin elasticity-improving cosmetic composition comprising Chestnut inner bark extract and Malt extract
KR100308178B1 (en) * 1997-11-10 2002-02-28 유상옥,송운한 Skin wrinkle improvement cosmetic composition containing yulpi extract
KR100376136B1 (en) * 1998-08-13 2003-06-18 주식회사 코리아나화장품 Astringent Cosmetic Composition Containing Yulpi Extract
JP2003292430A (en) * 2002-04-01 2003-10-15 Noevir Co Ltd Skin care preparation
JP2005139070A (en) * 2003-11-04 2005-06-02 Kanebo Cosmetics Inc Skin cosmetics
KR20100055099A (en) * 2008-11-17 2010-05-26 (주)아모레퍼시픽 Skin whitening cosmetic composition containing natural crop powders as exfoliation surface skin cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092960A (en) * 1995-06-15 1997-01-07 Watanabesan Shoten:Kk Dermatitis treating agent and treatment of dermatitis
JPH09175993A (en) * 1995-12-27 1997-07-08 Pairei:Kk Production of bathing agent
JPH09182574A (en) * 1996-01-05 1997-07-15 Pairei:Kk Production of chestnut tea
AU7961900A (en) * 1999-10-29 2001-05-14 Kyowa Hakko Kogyo Co. Ltd. Skin texture-improving agents
JP2002371276A (en) * 2001-06-14 2002-12-26 Kanebo Ltd Antioxidants, food and cosmetics using the same
KR100483539B1 (en) * 2002-12-10 2005-04-18 이진형 Composition for preventing or treating atopic dermatitis and process for preparation thereof
JP4090861B2 (en) * 2002-12-13 2008-05-28 クラシエフーズ株式会社 Antioxidants, foods and cosmetics using the same
CN101268847A (en) * 2007-03-23 2008-09-24 张宝林 Blood cleaning cola for eliminating sub-health
KR20080090169A (en) * 2007-04-04 2008-10-08 (주) 아디포젠 Mugwort or yulpi extract or weight-controlling composition containing scoparon isolated therefrom
JP2008195936A (en) * 2008-01-28 2008-08-28 Kracie Foods Ltd Antioxidant and food and cosmetics using the same
KR20080101821A (en) * 2008-08-27 2008-11-21 김선일 Skin external composition comprising safflower fraction

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100253843B1 (en) * 1997-02-14 2000-07-01 유상옥 Whitening agent containing Yulpi extract
KR100308178B1 (en) * 1997-11-10 2002-02-28 유상옥,송운한 Skin wrinkle improvement cosmetic composition containing yulpi extract
KR100376136B1 (en) * 1998-08-13 2003-06-18 주식회사 코리아나화장품 Astringent Cosmetic Composition Containing Yulpi Extract
KR20000065305A (en) * 1999-04-01 2000-11-15 유상옥 Skin care composition containing stabilized retinol, phytosphingosine, and Castaneae crenata extracts
KR20010092070A (en) * 2000-03-20 2001-10-24 유상옥,송운한 Skin elasticity-improving cosmetic composition comprising Chestnut inner bark extract and Malt extract
JP2003292430A (en) * 2002-04-01 2003-10-15 Noevir Co Ltd Skin care preparation
JP2005139070A (en) * 2003-11-04 2005-06-02 Kanebo Cosmetics Inc Skin cosmetics
KR20100055099A (en) * 2008-11-17 2010-05-26 (주)아모레퍼시픽 Skin whitening cosmetic composition containing natural crop powders as exfoliation surface skin cells

Also Published As

Publication number Publication date
CN102458156A (en) 2012-05-16
WO2010147440A2 (en) 2010-12-23
KR101338681B1 (en) 2013-12-09
KR20120027432A (en) 2012-03-21
JP2012530699A (en) 2012-12-06
CN105285986A (en) 2016-02-03

Similar Documents

Publication Publication Date Title
WO2010147440A3 (en) Health food or pharmaceutical composition comprising chestnut shell extract
GB201118656D0 (en) New compounds
MY189427A (en) Pyrazolyl quinoxaline kinase inhibitors
WO2014097151A3 (en) Autotaxin inhibitors
UA106634C2 (en) Solid pharmaceutical dosage form
MX349004B (en) New compounds.
HK1243410A1 (en) Novel compounds
GB201209613D0 (en) New compounds
MX366899B (en) New compounds.
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
MX2010014057A (en) Pyridine compounds.
NZ608116A (en) Triazine-oxadiazoles
WO2010092090A3 (en) Novel salts of sitagliptin
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
EP2995304A4 (en) Composition for preventing or treating symptoms of menopause comprising soybean extract comprising coumestrol as an active ingredient
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
WO2012162513A3 (en) Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase i inhibitors
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
WO2010147441A3 (en) Cosmetic composition comprising chestnut shell extract
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
WO2011139252A3 (en) Efervescent formulations comprising cefdinir
WO2012116992A3 (en) Oral use of a composition comprising steviol or isosteviol
WO2012007758A3 (en) Pharmaceutical formulations
WO2014122671A3 (en) Solid oral compositions of saxagliptin

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080035903.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10789767

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2012515997

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20117031657

Country of ref document: KR

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 10789767

Country of ref document: EP

Kind code of ref document: A2